logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

FDA issues alert over atezolizumab combined with paclitaxel for TNBC

Warning does not affect atezolizumab plus nab-paclitaxel, a combination approved in 90 countries.